Osaic Holdings
EVH icon

Osaic Holdings’s Evolent Health EVH Stock Holding History

Osaic Holdings’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59K Buy
25,862
+14,502
+128% +$46K ﹤0.01% 5081
2025
Q4 		$45.4K Buy
11,360
+505
+5% +$2.81K ﹤0.01% 5299
2025
Q3 		$104K Sell
10,855
-264
-2% -$2.56K ﹤0.01% 4740
2025
Q2 		$125K Buy
11,119
+5,537
+99% +$50.9K ﹤0.01% 4324
2025
Q1 		$52.9K Sell
5,582
-327
-6% -$3.3K ﹤0.01% 4674
2024
Q4 		$66.5K Buy
5,909
+4,943
+512% +$86.9K ﹤0.01% 4487
2024
Q3 		$27.3K Sell
966
-324
-25% -$8.35K ﹤0.01% 5164
2024
Q2 		$24.7K Sell
1,290
-7,035
-85% -$180K ﹤0.01% 5189
2024
Q1 		$273K Sell
8,325
-109
-1% -$3.48K ﹤0.01% 3417
2023
Q4 		$274K Buy
8,434
+3,745
+80% +$106K ﹤0.01% 3672
2023
Q3 		$128K Buy
4,689
+2,049
+78% +$57K ﹤0.01% 4320
2023
Q2 		$80K Sell
2,640
-2,188
-45% -$70.7K ﹤0.01% 4609
2023
Q1 		$157K Buy
4,828
+1,063
+28% +$33.6K ﹤0.01% 4065
2022
Q4 		$105K Sell
3,765
-1,669
-31% -$47.8K ﹤0.01% 4391
2022
Q3 		$196K Sell
5,434
-23,542
-81% -$829K ﹤0.01% 3768
2022
Q2 		$889K Sell
28,976
-1,078
-4% -$31.4K ﹤0.01% 2392
2022
Q1 		$994K Buy
30,054
+25,999
+641% +$681K ﹤0.01% 2587
2021
Q4 		$113K Buy
4,055
+1,135
+39% +$32.6K ﹤0.01% 4491
2021
Q3 		$90K Sell
2,920
-10
-0.3% -$240 ﹤0.01% 4623
2021
Q2 		$61K Sell
2,930
-720
-20% -$14.4K ﹤0.01% 4891
2021
Q1 		$76K Sell
3,650
-2,043
-36% -$38.9K ﹤0.01% 4562
2020
Q4 		$92K Buy
5,693
+362
+7% +$4.79K ﹤0.01% 4108
2020
Q3 		$67K Buy
5,331
+2,575
+93% +$30.3K ﹤0.01% 4100
2020
Q2 		$20K Sell
2,756
-6,910
-71% -$46.3K ﹤0.01% 4793
2020
Q1 		$53K Buy
+9,666
New +$86.3K ﹤0.01% 3928

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's EVH Position: Q1 2026 in Review

Osaic Holdings increased its Evolent Health (EVH) stake by 128% in Q1 2026, buying an estimated $46K and bringing the position to 25,862 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #5081.

Osaic Holdings first reported a position in EVH in Q1 2020 and has held it in 25 quarters since. The position peaked at $994K in Q1 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Osaic Holdings held 25,862 shares of Evolent Health worth $59K as of Q1 2026.
  • Osaic Holdings bought 14,502 Evolent Health shares in Q1 2026, an estimated $46K.
  • Evolent Health made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5081 holding.
  • Osaic Holdings first reported a position in Evolent Health in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Evolent Health position peaked at $994K in Q1 2022.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.